Kadriye Başkurt

13PUBLICATIONS
25CO-AUTHORS
Predictive and prognostic markersEpidemiological modellingCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Oct 06, 2026
Baseline 25-hydroxyvitamin D and progression-free survival in de novo metastatic hormone-sensitive prostate cancer: prognostic model development and external validation.

|Aug 20, 2026
Topical Diclofenac for Prevention of Capecitabine-Induced Hand-Foot Syndrome: A Prospective Real-World Study.

|Jun 25, 2026
Real-World 30-Day Mortality After the Last Dose of Immune Checkpoint Inhibitors: A Multicenter Retrospective Cohort Study in Turkey.

|Jun 18, 2026
Limb Compression Therapy and Chemotherapy-Induced Peripheral Neuropathy in Women With Gynecologic Cancers: A Prospective Self-Controlled Study(NEURO-GLOVE Trial).

|Jan 12, 2026
Impact of vitamin D deficiency and inflammatory biomarkers on pathological response to neoadjuvant chemotherapy in breast cancer.

Kadriye Başkurt, Galip Can Uyar, Enes Yeşilbaş

|Oct 06, 2025
Prognostic significance of liver-to-muscle FDG uptake ratio and ınflammatory biomarkers in small cell lung cancer.

Kadriye Başkurt, Semra Demirtaş Şenlik, Galip Can Uyar

Pageof 3

Frequent Collaborators

12 joint publications

Galip Can Uyar

11 joint publications

Enes Yeşilbaş

9 joint publications

Osman Sütcüoğlu

6 joint publications

Orhun Akdoğan